Related Experiment Videos
[Cardiotoxicity of fenoterol - ultramorphologic and morphometric studies of the rabbit myocardium]
Abstract:
Beta-sympathomimetic drugs in large doses can induce necrosis of the myocardium, according to animal-experimental studies mainly with isoproterenol. In the instance of its broad clinical application in tocolysis a possible cardiotoxic effect of fenoterol has also been discussed. It was interesting to study the ultramorphologic effects of fenoterol on rabbit myocardium after a ten-day-application period. These tests revealed no myocardial-toxic alterations after monotherapy or in combination with verapamil or prednisolone (applying therapy-equivalent doses); a morphometric-statistical analysis confirmed these findings.
Insights
Beta-sympathomimetic drugs can harm the heart. Studies on fenoterol in rabbits showed no myocardial toxicity, even with combined therapies, suggesting it is safe for treating preterm labor.
Area of Science:
- Cardiovascular Pharmacology
- Experimental Pathology
- Drug Safety Evaluation
Context:
- Beta-sympathomimetic drugs, like isoproterenol, are known cardiotoxins in high doses.
- Fenoterol is widely used in tocolysis (preventing preterm labor), raising concerns about potential cardiac side effects.
- Ultramorphologic examination is crucial for detecting subtle myocardial damage.
Purpose:
- To investigate the ultramorphologic effects of fenoterol on rabbit myocardium.
- To assess potential cardiotoxicity of fenoterol monotherapy.
- To evaluate cardiotoxicity when fenoterol is combined with verapamil or prednisolone.
Summary:
- Rabbit myocardium was examined after ten days of fenoterol administration.
- No myocardial-toxic alterations were observed with fenoterol monotherapy.
- Combined therapy with verapamil or prednisolone also showed no cardiotoxic effects.
Impact:
- Provides evidence against fenoterol-induced cardiotoxicity in a preclinical model.
- Informs clinical safety profiles for fenoterol use in tocolysis.
- Supports the continued use of fenoterol in obstetric practice based on cardiac safety data.